Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Avichai Shimoni
The Combination of Cyclosporine and Mycophenolate Mofetil Is Less Effective Than Cyclosporine and Methotrexate in the Prevention of Acute Graft-Versus Host Disease After Stem-Cell Transplantation From Unrelated Donors
American Journal of Hematology
Hematology
Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning
American Journal of Hematology
Hematology
Discovery of Tumoricidal DNA Oligonucleotides by Response-Directed in Vitro Evolution
Communications Biology
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Identification of Strong Intron Enhancer in the Heparanase Gene: Effect of Functional Rs4693608 Variant on HPSE Enhancer Activity in Hematological and Solid Malignancies
Oncogenesis
Cancer Research
Molecular Biology
Comparison of Cyclosporine/ Methotrextae and Cyclosporine/ Mycophenolate Combinations for Prevention of Acute Graft-Versus Host Disease After Allogeneic Stem Cell Transplantation From Unrelated Donors: A Single Center Retrospective Study
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Single Infusion of Donor Mononuclear Early Apoptotic Cells as Prophylaxis for Graft-Versus-Host Disease in Myeloablative HLA-Matched Allogeneic Bone Marrow Transplantation: A Phase I/IIa Clinical Trial
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Incidence, Risk Factors, Treatment and Outcome of Isolated Extramedullary Relapse After Allogeneic Stem Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Assessment of the Effect of Nilotinib (Tasigna) Maintenance Therapy After Allogeneic Stem Cell Transplantation in Patients With Advanced CML and Ph+ ALL on Immune Reconstitution and Lymphocyte Function
Biology of Blood and Marrow Transplantation
Transplantation
Hematology